These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2117831)

  • 1. [Changes in the interferon status of patients with viral hepatitis B when genetically engineered alpha 2-interferon is used].
    Pokrovskiĭ VI; Malinovskaia VV; Murzabaeva RT; Vasil'eva VI; Asratian AA
    Vopr Virusol; 1990; 35(2):135-8. PubMed ID: 2117831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The interferon reaction of the leukocytes and the natural killer activity in patients with acute viral hepatitis B undergoing interferon treatment].
    Golban TD; Cheshik SG; Kuznetsov VP; Beliaev DL; Grishchenko SV; Morgunov KM; Babaiants AA; Polikushina OE; Antonenko SM
    Vopr Virusol; 1994; 39(4):177-9. PubMed ID: 7998397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the activity of the natural killers under the influence of genetically engineered alpha 2-interferon in patients with viral hepatitis B].
    Malinovskaia VV; Murzabaeva RT; Bragina GS
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):97-101. PubMed ID: 2201157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Change in interferon status in patients with acute viral hepatitis during intramuscular and rectal administration of genetically engineered alpha-2-interferon].
    Malinovskaia VV; Neumoina MV; Budanov SV
    Vopr Virusol; 1994; 39(6):269-72. PubMed ID: 7536374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of recombinant alfa-2 interferon in treating patients with acute and chronic viral hepatitis B].
    Vovk AD; Tat'ianko NV; Fedorchenko SV; Liashok OV
    Lik Sprava; 1998; (7):117-21. PubMed ID: 10050478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of reaferon in treating patients with protracted viral hepatitis].
    Kokoreva LN; Zmyzgova AV; Nazarenko IV
    Ter Arkh; 1994; 66(2):21-4. PubMed ID: 8160137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of interferon on clinico-laboratory indicators in patients with acute viral hepatitis B].
    Pokrovskiĭ VI; Zmyzgova AV; Matveeva SM; Saltykov VP; Soibnazarov ISh
    Ter Arkh; 1986; 58(10):29-32. PubMed ID: 3798344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of using recombinant interferon alfa2 (reaferon) combined with antioxidants in children with acute hepatitis B].
    Reĭzis AR; Malinovskaia VV; Shekhade S; Drondina AK; Nikitina TS; Markarian AS; Nazarenko IV; Mikhaĭlov MI
    Pediatriia; 1992; (1):60-4. PubMed ID: 1614804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An assessment of the therapeutic efficacy of gene-engineered human alpha 2-interferon in patients with acute viral hepatitis B].
    Pokrovskiĭ VI; Zmyzgova AV; Botsvadze ESh; Andreĭchin MA; Frolov VM; Murzabaeva RT; Mesniankin AP; Kokareva LN; Malinovskaia VV
    Ter Arkh; 1990; 62(2):139-43. PubMed ID: 2186494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B].
    Andreĭchin MA; Rudchik AS; Borak VF
    Ter Arkh; 1988; 60(11):29-32. PubMed ID: 3238572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon preparations in the treatment of acute and chronic forms of hepatitis B].
    Botsvadze ESh; Katsitadze TK; Kuznetsov VP; Kvitashvili MA; Gogichaĭshvili ShSh
    Ter Arkh; 1988; 60(8):79-82. PubMed ID: 3067414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis.
    Kakumu S; Fuji A; Yoshioka K; Tahara H
    Hepatogastroenterology; 1989 Apr; 36(2):97-102. PubMed ID: 2499528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The problem of the interferon therapy of patients with chronic viral hepatitis].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):101-4. PubMed ID: 8525715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant alpha2-interferon substances in treating patients with acute hepatitis B with a mild course].
    Malinovskaia VV; Neumoina MV; Bragina GS
    Vopr Virusol; 1997; 42(4):182-5. PubMed ID: 9304301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reaferon and interferonogenes in the therapy of acute viral hepatitis B].
    Andreĭchin MA; Zmyzgova AV; Rudchik AS
    Klin Med (Mosk); 1991 Mar; 69(3):77-80. PubMed ID: 2067345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of recombinant alfa-2 interferon (reaferon) on the functional activity of natural killers in acute viral hepatitis B].
    Petrovskaia IA; Kushko LIa; Fedorchenko SV; Vovk AD; Listopad NK; Antoniak SN; Drannik GN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):56-7. PubMed ID: 8553758
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon in the management of chronic hepatitis B.
    Perrillo RP
    Dig Dis Sci; 1993 Apr; 38(4):577-93. PubMed ID: 8462360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The functioning of the interferon system in mycosis fungoides patients undergoing different methods of therapy].
    Faradzhev ZG
    Vestn Dermatol Venerol; 1990; (6):4-7. PubMed ID: 2120861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G; Meyer zum Büschenfelde KH
    Immunobiology; 1986 Sep; 172(3-5):255-61. PubMed ID: 3643162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The functioning of the interferon system with different methods and dosages of recombinant alpha 2-interferon (reaferon) administration].
    Malinovskaia VV; Murzabaeva RT; Manakhova LS; Mironova LL
    Vopr Virusol; 1989; 34(2):180-3. PubMed ID: 2474904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.